BGI Genomics
2025.04.26
01:22
BGI: Net loss of 52.6951 million yuan in the first quarter of 2025
BGI announced that its operating income in the first quarter of 2025 was 672 million yuan, a year-on-year decrease of 18.18%. Its net loss was 52.6951 million yuan, compared with a net profit of 12.4025 million yuan in the same period last year.
2025.03.07
17:31
Novogene: Signed a strategic cooperation agreement with BGI
Novazonics announced that it has signed a strategic cooperation agreement with BGI. The two parties will cooperate in the fields of reproductive genetics, tumor prevention and control, chronic disease management and infection prevention and control, and promote genomics from basic research to clinical medicine. The cooperation period is 5 years, from March 6, 2025 to March 5, 2030. The specific details of the cooperation will be subject to the signing of subsequent agreements. This cooperation is not expected to have a significant impact on the company's 2025 annual performance, and the impact on the company's future annual operating performance will depend on the specific cooperation situation in the future.
13:46
BGI and Novozymes Sign Cooperation Agreement
On March 6, BGI and Nanjing Novaeda Biotech Co., Ltd. ("Novaeda") officially signed a cooperation agreement. The two parties will focus on the fields of life sciences and in vitro diagnostics, aiming to jointly promote technological innovation and product application through complementary advantages, inject new impetus into the development of brain science and brain health, and create a new paradigm for the coordinated development of China's biotechnology.
2025.03.04
13:30
A-share gene sequencing concept stocks were locally active, with BGI Genomics rising more than 14%. Berry Genomics had previously hit the daily limit, followed by BGI, Daan Genetics, Dian Diagnostics and others.
13:27
Gene sequencing stocks were active locally, with BGI rising by more than 14%
Gene sequencing concept stocks were locally active, with BGI Genomics rising more than 14%. Berry Genomics had previously hit the daily limit, followed by BGI, Daan Genetics, Dian Diagnostics and others.
2025.03.01
11:54
What is the future profit model of the launched AI big model? BGI responds
Regarding the question of "the future profit model of the AI big model launched by the company", BGI stated during the institutional survey that BGI AI big model will consider cooperating with the hospital side in the future and give birth to diversified product forms and innovative business models. In terms of product form, it is possible to combine artificial intelligence technology with hospital diagnosis and treatment services through applications and other forms to provide users with personalized health testing assessments, disease warnings and diagnosis and treatment recommendations; in terms of profit model, in the future, the company considers achieving profitability by exporting big model technology to customers or providing services, which depends on product positioning and service content.
2025.02.26
19:23
Chinese business delegation visits Saudi Arabia
According to the China Council for the Promotion of International Trade, the China Council for the Promotion of International Trade organized a delegation of Chinese entrepreneurs to visit Saudi Arabia from February 25 to 27 to actively promote economic and trade exchanges between China and Saudi Arabia and deepen mutually beneficial and pragmatic cooperation between the business communities of the two countries. The delegation focused on introducing China's economic situation and the latest measures to expand opening up to Saudi political and business people, actively promoting the deepening and implementation of the "Belt and Road" initiative between China and Saudi Arabia, further deepening the cooperation between the business communities of the two countries in the field of industrial chain and supply chain, and welcomed Saudi Arabia to actively participate in the third Chain Expo. Business people in China and Saudi Arabia generally believe that the economic and trade cooperation between the two sides has great potential and broad prospects. Enterprises and institutions of both sides actively carried out business negotiations and achieved a number of cooperation results. During the visit, Yu Jianlong, Vice President of the China Council for the Promotion of International Trade, led a delegation of Chinese entrepreneurs to visit the Federation of Saudi Chambers of Commerce and Saudi Basic Industries Corporation, investigate Saudi Dragon City, BGI Saudi Precision Medicine Laboratory, etc., and held two exchange activities, the China-Saudi Entrepreneurs Symposium and the China-Saudi Entrepreneurs Roundtable.
11:31
A-share midday review: Shanghai Composite Index rebounded 0.50% in half a day, and the robot sector continued to explode
The three major A-share indexes rebounded collectively in the morning. As of noon, the Shanghai Composite Index rose by 0.50%, the Shenzhen Component Index rose by 0.24%, the ChiNext Index rose by 0.26%, and the Beijing Stock Exchange 50 Index rose by 2.19%. The market's half-day turnover was 1,176.2 billion yuan, an increase of 22.5 billion yuan from the previous day. More than 3,800 stocks rose in the market. In terms of sector themes, robots, auto parts, and solid-state batteries led the gains; agriculture, liquor, and medical services led the declines. On the market, robot concept stocks set off a daily limit surge, with Zhaowei Electromechanical, Lixing Shares, Baotong Technology, Zhongda Lide, Shanghai Electromechanical, Wuzhou Xinchun, and Zhongding Shares hitting the daily limit. Solid-state battery concept stocks led the gains, with Huafeng Shares and Sacred Sun Shares hitting the daily limit for four consecutive days, and Kosen Technology and Pulite hitting the daily limit. Auto parts concept stocks were active, with Shanzi Hi-Tech, Wanliyang, Yinlun Shares, and Ningbo Huaxiang hitting the daily limit. Pharmaceutical services led the decline, with Innovative Medical and BGI leading the decline.
2025.02.19
10:20
Smart medical sector fluctuated higher, with many stocks rising
The smart medical sector fluctuated higher. Desheng Technology had previously hit its daily limit, while KingMed Medical, BGI, International Medical, and Jiahe Meikang all rose.
2025.02.18
09:42
The medical services sector fell in early trading, with Dian Diagnostics falling more than 8%
The medical services sector fell in early trading, with Dian Diagnostics falling more than 8%, Berry Genomics falling more than 6%, and shares of Guangzheng Ophthalmology, Chengdu Pioneer, and BGI falling.
2025.02.14
13:14
AI medical concepts continue to rise, with more than 20 stocks rising by more than 10%
In the afternoon, the AI medical concept's rally expanded, with many stocks such as Xin Ganjiang, Anping, Jiahe Meikang, Celly Medical, KingMed Diagnostics, and Berry Genomics hitting their daily limit, while Dian Diagnostics, Xiangsheng Medical, Weining Health, and BGI rose by more than 10%.
2025.02.07
11:08
A-share AI medical concept stocks fluctuated and rose, with Meinian Health, Berry Genomics, and KingMed Diagnostics hitting their daily limit, and BGI Genomics rising by more than 10%. BGI, Sanyuan Genomics, Dian Diagnostics, and Chengdu Pioneer were among the top gainers.
2025.02.06
11:11
A-share AI medical concept stocks fluctuated higher, with BGI hitting the 20CM daily limit, followed by Digital Human, BiDe Pharmaceuticals, Hongbo Pharmaceuticals, Anping, Berry Genomics, Chengdu Pioneer and others.
2025.02.05
17:02
BGI: Decided to launch shareholder feedback activities in 2025
BGI announced that the company has decided to launch the "BGI 2025 Shareholder Rewards Event". Shareholders who have held shares for more than one year by 15:00 on February 5, 2025 can upload relevant proof of shareholding time to receive a free Huachangkang intestinal health test gift box. This reward event is limited and will be distributed in sequence. Shareholders registered as of 15:00 on February 5, 2025 can apply for the company's shareholder-exclusive coupons, which can be used to deduct the consumption of any product or product combination in the BGI Mall. Each shareholder can only receive a shareholder-exclusive coupon once.
2024.12.06
14:21
Are US lawmakers considering changes to the biosafety bill? BGI Investor Relations Department responded: We are not aware of this news
CRO concept stocks fluctuated and strengthened, WuXi AppTec hit the daily limit in the afternoon, and BGI rose more than 2%. On the news front, some media reported that the US biosafety law said that US lawmakers are considering changing the bill. The compromise version includes adding administrative review links for related companies, rather than automatically prohibiting biopharmaceutical companies from cooperating with Chinese companies. In this regard, the reporter contacted BGI's investor relations department as an investor, and the relevant person said, "I have no information about this. Please refer to the company's announcement." (21 Finance)
Load More
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
Weekly Highlights
Hong Kong Stock Midday Review: Hang Seng Index fell 1.21%, Hang Seng Technology Index fell 2.04%

2025-04-24

Tesla's gains in US stocks expanded to 5%

2025-04-22

Ideal Auto's Ring OS is officially open source, and the code is now available for download

2025-04-28

BYD: Net profit in the first quarter increased by 100.38%

2025-04-25

Citi: Lowered JD.com's (JD.O) target price from $56 to $51.

2025-04-28

ASIA TECH WIRE

Grasp technology trends

Download